1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > China Diabetes Market Outlook 2018

China Diabetes Market Outlook 2018

  • November 2013
  • -
  • RNCOS
  • -
  • 50 pages

Approximately 92 Million people in China had diabetes in 2012 and the number is estimated to reach approximately 130 Million by 2030. The country’s diabetic population is rapidly growing owing to factors, including growing ageing population, rising obesity rates and increasing westernization. Not only this, the country has a significant share in the diabetes market globally. Chinese government authorities are spending a huge amount of money on diabetics. The growth in diabetes drug spending in the country is currently running at 11% and is estimated to reach approximately US$ 4.6 Billion by 2018.

In RNCOS’ latest report “China Diabetes Market Outlook 2018”, the country’s diabetes market has been segmented into oral drugs, insulin drugs, insulin delivery devices and self monitoring glucose monitoring devices. RNCOS’ analysts have identified the growth potential of diabetes with respect to each of these segments thereby highlighting the potential for market players. The report also highlights the healthcare expenditures pertaining to diabetes treatment in the country which will help clients in understanding the future demand scenario.

The report provides an exhaustive overview of the technological developments for insulin delivery devices and glucose monitoring systems which would help the client understand various advanced technology systems available in the market. The overall study analyzes the current and future outlook of diabetes drugs as well as insulin delivery device systems in China.

The report covers the major drivers and trends impacting the China diabetes market. It provides an insight about strategic activities by major market players. Several companies have been trying to tap the potential market demand for diabetes treatment. However, market players have been extending their product portfolios in order to gain their own market shares.

In the end, RNCOS concludes with a competitive analysis of major market players providing their business overviews specific to the China diabetes market along with their product portfolios. It also elucidates the key developments of the players pertaining to this market and provides an overview of the regulatory environment for diabetes and patient profile that will help clients in formulating market strategies and assess opportunity areas in the China diabetes market.

Table Of Contents

China Diabetes Market Outlook 2018
1. Analyst View
2. Research Methodology
3. Patient Profile Analysis
4. Cost Implications
5. Market Drivers and Trends
5.1 Rising Prevalence of Obesity
5.2 Increasing Investment from Global Giants
5.3 Advancement in Insulin Pens Improving the Delivery Mechanism
6. Diabetes Drugs Market
6.1 Oral Diabetic Drugs Market
6.1.1 By Drugs
6.2 Insulin Drugs Market
6.2.1 By Players
7. Insulin Delivery Devices Market
7.1 Insulin Pens
7.2 Insulin Syringes
8. Glucose Monitoring Devices Market
8.1 Self Monitoring Blood Glucose (SMBG) Devices
9. Government Regulations and Initiatives
10. Key Players
10.1 Novo Nordisk
10.2 Eli Lilly
10.3 Sanofi-Aventis
10.4 Tonghua Dongbao Pharmaceutical Co. Ltd.
10.5 Merck and Co.
10.6 Tianjin Takeda Pharmaceuticals Co Ltd.
10.7 Bayer
10.8 Medtronic
10.9 Terumo Corporation

List of Figures:

Figure 3-1: Prevalence of Diabetes in Age Group 20-79 Years (%), 2012 and 2030
Figure 3-2: Diabetic Population in Age Group 20-79 Years (Million), 2012 and 2030
Figure 4-1: India and China - National Income Loss by Diabetes and Cardiovascular Diseases (Billion US$), 2005 to 2015
Figure 6-1: Oral Diabetic Drugs Market (Billion US$), 2012-2018
Figure 6-2: Insulin Drugs Market (Billion US$), 2012-2018
Figure 6-3: Insulin Market Share by Player (2012)
Figure 7-1: Insulin Delivery Device Market (Million US$), 2012-2018
Figure 7-2: Insulin Pen Market (Million US$), 2012-2018
Figure 7-3: Insulin Syringes Market (Million US$), 2012-2018
Figure 8-1: SMBG Devices Market (Million US$), 2012-2018

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

  • $ 4995
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence ...

Diabetic Gastroparesis  - Market Insights, Epidemiology and Market Forecast-2023

Diabetic Gastroparesis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Diabetic Gastroparesis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Diabetic Gastroparesis fo ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.